Repurchase Agreements in the Pharmaceuticals Industry
17 Contracts & Agreements
- Alexza Pharmaceuticals Inc. (3 contracts)
- Amphastar Pharma (1)
- Applied BioSciences Corp. (1)
- Artemis Therapeutics, Inc. (2)
- Assertio Therapeutics, Inc (1)
- FERMAVIR PHARMACEUTICALS, INC. (1)
- GridIron BioNutrients, Inc. (1)
- Innoviva, Inc. (1)
- Item 9 Labs Corp. (1)
- OCULAR THERAPEUTIX, INC (1)
- POLYDEX PHARMACEUTICALS LTD (1)
- SALIX PHARMACEUTICALS LTD (1)
- TITAN PHARMACEUTICALS INC (2)
- Share Repurchase Agreement by and between Amphastar Nanjing Pharmaceuticals, Inc., Nanjing Qianqia Enterprise Management Consulting (LLP), Nanjing Zhongpan Enterprise Management... (Amphastar Pharma, Filed With SEC on August 9, 2021)
- SHARE REPURCHASE AGREEMENT (Innoviva, Inc., Filed With SEC on May 20, 2021)
- Stock Repurchase Agreement, dated April 19, 2018, by and among the Company, Food for Athletes, Inc., a California corporation, Darren Long and Brian Martinho (GridIron BioNutrients, Inc., Filed With SEC on December 14, 2018)
- Intellectual Property Purchase and Stock Repurchase Agreement, dated February 9, 2018, by and among the Company, Damian Marley and Daniel Dalton (Applied BioSciences Corp., Filed With SEC on March 5, 2018)
- STOCK REPURCHASE AGREEMENT (OCULAR THERAPEUTIX, INC, Filed With SEC on June 20, 2014)
- SHARE RE-PURCHASE AGREEMENT (Item 9 Labs Corp., Filed With SEC on December 24, 2013)
- NOTE REPURCHASE AGREEMENT (SALIX PHARMACEUTICALS LTD, Filed With SEC on March 16, 2012)
- AMENDED AND RESTATED ROYALTY REPURCHASE AGREEMENT (TITAN PHARMACEUTICALS INC, Filed With SEC on November 17, 2011)
- STOCK REPURCHASE AGREEMENT (Artemis Therapeutics, Inc., Filed With SEC on September 6, 2011)
- STOCK REPURCHASE AGREEMENT (Artemis Therapeutics, Inc., Filed With SEC on September 6, 2011)
- ROYALTY REPURCHASE AGREEMENT (TITAN PHARMACEUTICALS INC, Filed With SEC on March 18, 2011)
- AZ-004 (Staccato loxapine). We are developing AZ-004 for the treatment of acute agitation in patients with schizophrenia or bi-polar disorder. In March 2007, we announced positive... (Alexza Pharmaceuticals Inc., Filed With SEC on March 17, 2008)
- AZ-004 (Staccato loxapine). We are developing AZ-004 for the treatment of acute agitation in patients with schizophrenia or bi-polar disorder. In March 2007, we announced positive... (Alexza Pharmaceuticals Inc., Filed With SEC on March 17, 2008)
- AZ-004 (Staccato loxapine). We are developing AZ-004 for the treatment of acute agitation in patients with schizophrenia or bi-polar disorder. In March 2007, we announced positive... (Alexza Pharmaceuticals Inc., Filed With SEC on March 17, 2008)
- FERMAVIR PHARMACEUTICALS, INC. REPURCHASE OPTION AGREEMENT (FERMAVIR PHARMACEUTICALS, INC., Filed With SEC on April 6, 2006)
- CONVERTIBLENOTE REPURCHASE AGREEMENT (Assertio Therapeutics, Inc, Filed With SEC on June 29, 2005)
- WARRANT AND REPURCHASE AGREEMENT (POLYDEX PHARMACEUTICALS LTD, Filed With SEC on April 30, 2004)
